Collaborative and Joint Working

At UCB, we are committed to being a partner to the NHS to enable patients to benefit from new treatments in immunology, neurology and rare diseases. We believe that collaborations can improve patient outcomes, reduce health inequalities and lead to more efficient use of resources. 

We do this in two ways, both defined by the Association of the British Pharmaceutical Industry (ABPI) Code of Practice:

• Collaborative working (of which seven projects exist in the UK)
• Joint working (of which three projects exist in the UK) 

Collaborative work involves partnering with organisations to implement initiatives that enhance patient care, benefit patients, or support the NHS while maintaining patient care at minimum.

Joint working is a type of collaborative working between pharmaceutical companies and the NHS and is always centred on patients.

You can find examples of all our collaborative and joint working initiatives below: